Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Showing news for:AAREYDRUGS
Clear all filters
positive
ET Markets - Industry 7d ago
Sun Pharma secures relief in 'Pantocid' trademark dispute
Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.
AAREYDRUGSABGSECAKUMSSPARCFinancial ServicesHealthcare
positive
CNBC TV18 - Markets 51d ago
Akums Drugs, subsidiary Akumentis Healthcare face ₹134 crore Income Tax demand
Shares of Akums Drugs and Pharmaceuticals Ltd ended at ₹513.00, down by ₹6.70, or 1.29%, on the BSE.
AAREYDRUGSAKUMSBSEHCGHCG-REHEALTHCAREMOHEALTHFinancial ServicesHealthcare